Bifidobacterium spp.

Generic Name: Bifidobacterium spp.

Drug Type: Biotech

Unique Ingredient Identifier: IO1WP3918D

Clinical Trials

Probiotics Combined with Enteral Nutrition Reduces Postoperative Infectious Complications in PD

Phase 1

Recruiting

Conditions: Infectious Complications

Interventions: Drug: Bifidobacterium Bifidum Oral Capsule

First Posted Date: 2024-12-06

Last Posted Date: 2024-12-06

Lead Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Target Recruit Count: 68

Registration Number: NCT06719596

Locations: 🇨🇳
321 Zhongshan Road, Nanjing Gulou Hospital, Gulou District, Nanjing, Jiangsu Province, China, Nanjing, Jiangsu, China

Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

Not Applicable

Completed

Conditions: Adolescent Depression

Interventions: Drug: Escitalopram Oxalate
Drug: Bifidobacterium
Device: High-frequency rTMS

First Posted Date: 2024-03-22

Last Posted Date: 2024-03-22

Lead Sponsor: Zhen-Hong Hu

Target Recruit Count: 100

Registration Number: NCT06325605

Locations: 🇨🇳
Tangshan Workers' Hospital, Tangshan, Hebei, China

Probiotics for Gallstones in Post-bariatric Surgery Patients

Not Applicable

Recruiting

Conditions: Gallstone Attack
Gallstone
Bariatric Surgery Candidate
Gastrointestinal Quality of Life Index
Probiotics

Interventions: Drug: Bifidobacterium group
Drug: Ursodoxycholic acid group

First Posted Date: 2024-03-01

Last Posted Date: 2024-03-01

Lead Sponsor: Shandong Linglong Yingcheng Hospital

Target Recruit Count: 400

Registration Number: NCT06287931

Locations: 🇨🇳
Shandong Linglong Yingcheng Hospital, Yantai, Shandong, China

Hyperbilirubinemia in Full-term Neonates

Phase 4

Recruiting

Conditions: Hyperbilirubinemia, Neonatal

Interventions: Other: Sunbathing
Other: Sunbathing and the Oral bifidobacterium triple live powder
Other: Conventional treatment
Drug: Oral bifidobacterium triple live powder

First Posted Date: 2024-02-02

Last Posted Date: 2024-02-02

Lead Sponsor: Zhuhai Center for Maternal and Child Health Care

Target Recruit Count: 200

Registration Number: NCT06238349

Locations: 🇨🇳
Zhuhai Center for Maternal and Child Health Care, Zhuhai, Guangdong, China

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Phase 4

Not yet recruiting

Conditions: Cancer Therapy-related Cardiovascular Toxicity

Interventions: Drug: Bifidobacterium Bifidum Oral Capsule
Drug: Cisplatin
Drug: Carboplatin
Drug: Paclitaxel
Drug: Atlizumab

First Posted Date: 2023-02-16

Last Posted Date: 2023-02-16

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 200

Registration Number: NCT05730777

Locations: 🇨🇳
Peking University Third Hospital, Beijing, China

Effect of Probiotics on Eradication of Persistent H.Pylori Infection

Not Applicable

Not yet recruiting

Conditions: Persistent Helicobacter Pylori Infection

Interventions: Drug: Bifidobacterium Infants plus Enterococcus Feacium plus Lactobacillus Acidophilus

First Posted Date: 2023-01-09

Last Posted Date: 2023-01-09

Lead Sponsor: Tanta University

Target Recruit Count: 92

Registration Number: NCT05674864

Locations: 🇪🇬
Faculty of medicine- Zagazig University, Zagazig, Sharkia, Egypt

Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy

Phase 1

Recruiting

Conditions: Advanced Hepatocellular Carcinoma

Interventions: Drug: Bifidobacterium Bifidum Oral Product

First Posted Date: 2022-11-17

Last Posted Date: 2022-11-17

Lead Sponsor: Sun Yat-sen University

Target Recruit Count: 30

Registration Number: NCT05620004

Locations: 🇨🇳
The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Effect of Probiotics on Helicobacter Pylori Eradication

Phase 4

Conditions: Helicobacter Pylori Eradication

Interventions: Drug: Bifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapy
Drug: Bifidobacterium tetrad live bacteria tablet placebo plus Helicobacter pylori quadruple eradication therapy

First Posted Date: 2019-07-26

Last Posted Date: 2019-12-04

Lead Sponsor: Hangzhou Grand Biologic Pharmaceutical, Inc.

Target Recruit Count: 238

Registration Number: NCT04034641

Locations: 🇨🇳
Xi'an Central Hospital, Xi'an, Shanxi, China
🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Probiotics Attenuate Postoperative Cognition Decline

Not Applicable

Conditions: Necrosis of Femoral Head
Knee Osteoarthritis
Lumbar Disc Herniation
Fracture of Neck of Femur

Interventions: Drug: Bifidobacterium triple live capsule
Drug: Placebos

First Posted Date: 2019-07-12

Last Posted Date: 2022-05-02

Lead Sponsor: RenJi Hospital

Target Recruit Count: 220

Registration Number: NCT04017403

Locations: 🇨🇳
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, Shanghai, China
🇨🇳
Jin Cheng people's hospital, Jincheng, Shanxi, China
🇨🇳
Renji Hospital, Shanghai, Shanghai, China

Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus

Phase 2

Completed

Conditions: Oral Lichen Planus

Interventions: Drug: Bifidobacterium animalis subsp. lactis HN019
Drug: Clobetasol propionate 0.05%

First Posted Date: 2017-12-29

Last Posted Date: 2020-03-27

Lead Sponsor: University of Sao Paulo

Target Recruit Count: 22

Registration Number: NCT03386643

Locations: 🇧🇷
School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy